Investor
Mubadala Capital
2$2.54bn$2.2bn0
Startups backed by Mubadala Capital that were acquired: 2 exits so far, with the buyer, the price where disclosed and every source.
Photo: Quintin Soloviev / Wikimedia Commons, CC BY 4.0Johnson & Johnson to buy eye-drug startup Ollin Biosciences for $2.2 billion upfront
Founded in 2023, Ollin could fetch up to about $3.3 billion with milestones, while Blackstone has agreed to pay $750 million toward the Phase 3 trials of its lead drug.
$2.2bn$430mSeries BCorporate
Latest in Mubadala CapitalTurkey · Commerce & marketingUber agrees to buy Getir's Turkish food delivery business for $335 million

All Mubadala Capital exitsOpen tracker →
Johnson & Johnson → Ollin Biosciences$2.2bn$1bn+Uber → Getir$335m$250m–1bn